Psychiatric disorders in children with demyelinating diseases of the central nervous system

The profile of psychiatric disorders associated with multiple sclerosis (MS) may differ in children. We aimed to assess the risk of psychiatric disorders in children with MS and other demyelinating diseases, and vice versa.We analyzed linked English Hospital Episode Statistics, and mortality data, 1...

Full description

Bibliographic Details
Main Authors: Pakpoor, J, Goldacre, R, Schmierer, K, Giovannoni, G, Waubant, E, Goldacre, M
Format: Journal article
Language:English
Published: SAGE Publications 2017
_version_ 1797059013524848640
author Pakpoor, J
Goldacre, R
Schmierer, K
Giovannoni, G
Waubant, E
Goldacre, M
author_facet Pakpoor, J
Goldacre, R
Schmierer, K
Giovannoni, G
Waubant, E
Goldacre, M
author_sort Pakpoor, J
collection OXFORD
description The profile of psychiatric disorders associated with multiple sclerosis (MS) may differ in children. We aimed to assess the risk of psychiatric disorders in children with MS and other demyelinating diseases, and vice versa.We analyzed linked English Hospital Episode Statistics, and mortality data, 1999-2011. Cohorts were constructed of children admitted with MS and other central nervous system (CNS) demyelinating diseases. We searched for any subsequent episode of care with psychiatric disorders in these cohorts and compared to a reference cohort.Children with CNS demyelinating diseases had an increased rate of psychotic disorders (rate ratio (RR) = 5.77 (95% confidence interval (CI) = 2.48-11.41)); anxiety, stress-related, and somatoform disorders (RR = 2.38 (1.39-3.81)); intellectual disability (RR = 6.56 (3.66-10.84)); and other behavioral disorders (RR = 8.99 (5.13-14.62)). In analysis of the pediatric MS cohort as the exposure, there were elevated rates of psychotic disorders (RR = 10.76 (2.93-27.63)), mood disorders (RR = 2.57 (1.03-5.31)), and intellectual disability (RR = 6.08 (1.25-17.80)). In reverse analyses, there were elevated rates of a recorded hospital episode with CNS demyelinating disease after a previous recorded episode with anxiety, stress-related, and somatoform disorders; attention-deficit hyperactivity disorder (ADHD); autism; intellectual disability; and other behavioral disorders.This analysis of a national diagnostic database provides strong evidence for an association between pediatric CNS demyelinating diseases and psychiatric disorders, and highlights a need for early involvement of mental health professionals.
first_indexed 2024-03-06T19:58:14Z
format Journal article
id oxford-uuid:266289b3-2136-4e4a-93b8-82f792eaea9c
institution University of Oxford
language English
last_indexed 2024-03-06T19:58:14Z
publishDate 2017
publisher SAGE Publications
record_format dspace
spelling oxford-uuid:266289b3-2136-4e4a-93b8-82f792eaea9c2022-03-26T12:00:37ZPsychiatric disorders in children with demyelinating diseases of the central nervous systemJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:266289b3-2136-4e4a-93b8-82f792eaea9cEnglishSymplectic Elements at OxfordSAGE Publications2017Pakpoor, JGoldacre, RSchmierer, KGiovannoni, GWaubant, EGoldacre, MThe profile of psychiatric disorders associated with multiple sclerosis (MS) may differ in children. We aimed to assess the risk of psychiatric disorders in children with MS and other demyelinating diseases, and vice versa.We analyzed linked English Hospital Episode Statistics, and mortality data, 1999-2011. Cohorts were constructed of children admitted with MS and other central nervous system (CNS) demyelinating diseases. We searched for any subsequent episode of care with psychiatric disorders in these cohorts and compared to a reference cohort.Children with CNS demyelinating diseases had an increased rate of psychotic disorders (rate ratio (RR) = 5.77 (95% confidence interval (CI) = 2.48-11.41)); anxiety, stress-related, and somatoform disorders (RR = 2.38 (1.39-3.81)); intellectual disability (RR = 6.56 (3.66-10.84)); and other behavioral disorders (RR = 8.99 (5.13-14.62)). In analysis of the pediatric MS cohort as the exposure, there were elevated rates of psychotic disorders (RR = 10.76 (2.93-27.63)), mood disorders (RR = 2.57 (1.03-5.31)), and intellectual disability (RR = 6.08 (1.25-17.80)). In reverse analyses, there were elevated rates of a recorded hospital episode with CNS demyelinating disease after a previous recorded episode with anxiety, stress-related, and somatoform disorders; attention-deficit hyperactivity disorder (ADHD); autism; intellectual disability; and other behavioral disorders.This analysis of a national diagnostic database provides strong evidence for an association between pediatric CNS demyelinating diseases and psychiatric disorders, and highlights a need for early involvement of mental health professionals.
spellingShingle Pakpoor, J
Goldacre, R
Schmierer, K
Giovannoni, G
Waubant, E
Goldacre, M
Psychiatric disorders in children with demyelinating diseases of the central nervous system
title Psychiatric disorders in children with demyelinating diseases of the central nervous system
title_full Psychiatric disorders in children with demyelinating diseases of the central nervous system
title_fullStr Psychiatric disorders in children with demyelinating diseases of the central nervous system
title_full_unstemmed Psychiatric disorders in children with demyelinating diseases of the central nervous system
title_short Psychiatric disorders in children with demyelinating diseases of the central nervous system
title_sort psychiatric disorders in children with demyelinating diseases of the central nervous system
work_keys_str_mv AT pakpoorj psychiatricdisordersinchildrenwithdemyelinatingdiseasesofthecentralnervoussystem
AT goldacrer psychiatricdisordersinchildrenwithdemyelinatingdiseasesofthecentralnervoussystem
AT schmiererk psychiatricdisordersinchildrenwithdemyelinatingdiseasesofthecentralnervoussystem
AT giovannonig psychiatricdisordersinchildrenwithdemyelinatingdiseasesofthecentralnervoussystem
AT waubante psychiatricdisordersinchildrenwithdemyelinatingdiseasesofthecentralnervoussystem
AT goldacrem psychiatricdisordersinchildrenwithdemyelinatingdiseasesofthecentralnervoussystem